Saraswati Sukumar

14PUBLICATIONS

93CO-AUTHORS

Metabolomic chemistryPredictive and prognostic markersNanomaterialsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 23, 2026

Development of the cf-MMSP assay for enhanced analytical sensitivity of methylated DNA in breast cancer liquid biopsy.

|Jan 01, 2025

Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer Risk.

Kala Visvanathan, Ashley Cimino-Mathews, Mary Jo Fackler

|Apr 20, 2024

Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.

Mary Jo Fackler, Madison Pleas, Youran Li

|Jun 16, 2023

Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer.

Bozhao Li, Feilong Qi, Fei Zhu

|Dec 19, 2022

Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial.

Kala Visvanathan, Leslie Cope, Mary Jo Fackler

|Sep 27, 2022

HOXA5-Mediated Stabilization of IκBα Inhibits the NF-κB Pathway and Suppresses Malignant Transformation of Breast Epithelial Cells.

Priya Pai, Guannan Wang, Wei Wen Teo

Pageof 3

Frequent Collaborators

Mary Jo Fackler

Guannan Wang

Antonio C Wolff

Preethi Korangath

Kala Visvanathan

Vered Stearns

Leslie Cope

Christopher VandenBussche

2 joint publications

Bradley M Downs

1 joint publications

Elizabeth T Henderson

Frequent Collaborators

Mary Jo Fackler

Guannan Wang

Antonio C Wolff

Preethi Korangath